Legal & Regulatory

Deciding The Future Of Work

All-virtual, on-site only or maybe a blended approach? Mandate vaccinations—or not? Think hard: What you choose now will have long-reaching effects on your company—and its culture.

SEC’s Elad Roisman: 5 Ideas To Get A Grip On ESG Compliance Costs

Roisman tells directors that SEC should “consider tailoring new rules to mitigate costs” before embarking on a widely-anticipated wave of ESG rulemaking.

Biden’s Focus On Climate Will Challenge Boards

To achieve the President's ambitious goals, his administration will need cooperation from corporations. What boards and CEOs need to know.

After Covid, Get Ready To Get Sued

A flood of post-pandemic litigation is forming. A field guide to what’s ahead.

More Director Accountability Likely Means Higher Levels Of D&O Insurance

Boards are increasingly being held responsible for climate change related natural disasters, fraud and corruption allegations, and various other ESG-related lawsuits.

A Wrong Poison Pill

Delaware Court invalidates Williams’ Poison Pill and finds that Williams’ board has breached its fiduciary duties.

Corporate Board Member Institute

The leading continuing education program for public company boards.

Directors’ Outlook For Economy Dims To Pre-Vaccine Levels On Inflation Fears

Our gauge of U.S. public company board member confidence is now just 3 percent above where it was last fall, before Covid-19 vaccines were released.